Mill

ion

s ($

)

Part the Cloud Investigator by Year Awarded

PTC

GOV

Foundations

Venture/ Corporate

2013 2015 2016

Private

Indirect Funding*

* government, foundation,

corporate/ venture capital and individual support that is indirectly related to the Part the Cloud Translational award.

2017

1 Michael Weiner

2 Anne Longo

3 Adam Boxer

4 Dale Bredesen

5 Keith Vossel

6 Ahmad Salehi

7 Stephen Cunnane

8 Whitney Wharton

9 Giulio Pasinetti

10 Tim West

11 Russell Swerdlow

12 Paul A. Newhouse

13 Mitchel Kling

14 Joseph Foss

15 Isidro Ferrer

16 John Olichney

17 Anthony Oliva

18 HuntingtonPotter

19 Franz Hefti

20 Linda Van Eldik

21 Mark Tuszynski

22 Krista Lanctot

23 Manfred Windisch

50

40

30

20

10

4

5

3

2

1

0 1 3 5 7 9 11 13 15 17 19 21 23

Part the Cloud Awardees – Funding

Preclinical Phase 1 Phase 2

TPI-287

F03*

Perindopril

BDPP Treatment

Oxaloacetate PPI-1011 SCCF-3012 NPT088

NTRX-07 MW189 BDNF Mesenchymal Stem Cells VU0467319

PTC Investment to Phase 1

LM11A-31-BHS C2N-8E12 (ABBV-8E12)

PTC Investment to Phase 1; Additional $ to Phase 2

Levetiracetam Formoterol*

Senicapoc GM-CSF Sativex

PTC Clinical Pipeline

* Studies not continued due to recruitment challenges.

PTC Investment to Phase 2

N-acetylsysteine (NAC)

MW150

Global Reach Over 100 Researchers in 13 Countries Provide Expert Review

Global Reach Evaluated Over 400 Clinical Studies from 26 Countries

Global Reach Advancing Over 20 Clinical Trials Around the World